NSAID

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
271	強直性脊椎炎	21

271. 強直性脊椎炎

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

trials per page:

Showing 1 to 10 of 21 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05527444 (ClinicalTrials.gov)	March 15, 2022	6/5/2022	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	The Clinical Efficacy and the Changes of Immune Cells Subsets With Bioagents in Ankylosing Spondylit ...	Ankylosing Spondylitis	Drug: Secukinumab 150 mg/ml;Drug: Adalimumab Ab;Drug: NSAID;Drug: Thalidomide Pill	Qilu Hospital of Shandong University	NULL	Recruiting	18 Years	65 Years	All	100	Phase 4	China
2	NCT04885751 (ClinicalTrials.gov)	June 1, 2021	26/4/2021	Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy	Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy in Patients Wi ...	Rheumatoid Arthritis;Osteoarthritis;Ankylosing Spondylitis;Other Musculoskeletal Disorder;Gastric Ul ...	Drug: Eupatilin;Drug: Rebamipide	Seoul National University Boramae Hospital	Dong-A ST Co., Ltd.	Not yet recruiting	19 Years	70 Years	All	50	Phase 4	NULL
3	ChiCTR2100043171	2021-02-08	2021-02-07	Efficacy and safety of iguratimod combined with NSAIDs in the treatment of AXSPA /AS in the real wor ...	Efficacy and safety of iguratimod combined with NSAIDs in the treatment of AXSPA /AS in the real wor ...	Axial spinal arthritis/ankylosing spondylitis	test group:Iguratimod;	Qilu Hospital of Shandong University	NULL	Recruiting			Male	test group:278;	Phase 4	China
4	ChiCTR2000034142	2019-04-01	2020-06-26	Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ...	Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ...	Ankylosing spondylitis	Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group ...	Jiangsu Province Hospital of TCM	NULL	Pending	25	70	Both	Experimental group:40;Experimental group 2:40;NSAID:40;	N/A	China
5	ITMCTR2000003433	2019-04-01	2020-06-26	Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ...	Study on TCM Syndrome Classification and Diagnosis and Treatment of Ankylosing Spondylitis by Metabo ...	Ankylosing spondylitis	Experimental group:Take Chinese medicine preparation Wen-Shen Juan-Bi-Tang orally;Experimental group ...	Jiangsu Province Hospital of TCM	NULL	Pending	25	70	Both	Experimental group:40;Experimental group 2:40;NSAID:40;	N/A	China
6	NCT02758782 (ClinicalTrials.gov)	September 2016	20/4/2016	NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage i ...	COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy ...	Ankylosing Spondylitis	Biological: Golimumab;Drug: Celecoxib	Charite University, Berlin, Germany	NULL	Completed	18 Years	N/A	All	156	Phase 4	Germany
7	EUCTR2016-000615-33-DE (EUCTR)	29/07/2016	06/07/2016	Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy ...	Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy ...	ankylosing spondylitis (AS) MedDRA version: 21.1;Level: LLT;Classification code 10041672;Term: Spond ...	Trade Name: Simponi Trade Name: Celebrex	Charite Universitaetsmedizin	NULL	Not Recruiting			Female: yes Male: yes	170	Phase 4	Germany
8	NCT02763046 (ClinicalTrials.gov)	May 31, 2016	3/5/2016	Study to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing E ...	A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine ...	Ankylosing Spondylitis	Drug: Secukinumab (AIN457) 150 mg s.c.;Drug: Placebo - Secukinumab (AIN457) 150 mg s.c.	Novartis Pharmaceuticals	NULL	Completed	18 Years	N/A	All	211	Phase 4	Germany
9	EUCTR2015-004575-74-DE (EUCTR)	16/03/2016	18/02/2016	Clinical study to examine the clinical efficacy and the NSAID-sparing effect of Secukinumab in patie ...	A randomized, double-blind, placebo-controlled multicenter study of Secukinumab (AIN457) to examine ...	Ankylosing Spondylitis MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylosing ...	Trade Name: Cosentyx Product Name: Secukinumab Product Code: AIN457 INN or Proposed INN: SECUKINUMAB Oth ...	Novartis Pharma GmbH	NULL	Not Recruiting			Female: yes Male: yes	190	Phase 4	Germany
10	NCT02469753 (ClinicalTrials.gov)	October 23, 2015	9/6/2015	Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Pati ...	Interest of Continuous Non-Steroidal Anti-Inflammatory Drug Treatment in Ankylosing Spondylitis Pati ...	Ankylosing Spondylitis	Drug: NSAIDs;Drug: anti-TNF	University Hospital, Bordeaux	NULL	Active, not recruiting	18 Years	N/A	All	188	Phase 3	France;Monaco

First Previous1 2 3Next Last